Inhibits ACE with a Ki of 1.6 uM, and targets B2 bradykinin receptor (BDKRB2). Provokes contraction of smooth muscle preparation (ileum). In vivo, induces an early hyperalgesic effects in living rats after intraplantar injection (By similarity). Expressed by the skin glands. [Thr6]-Bradykinin RA-11. [Thr6]-Bradykinin. [Thr6]-Bradykinin. Belongs to the bradykinin-related peptide family.